Zollinger-Ellison Syndrome

Zollinger-Ellison syndrome is a rare disease that is associated with the development of pancreatic adenoma, which is capable of producing large amounts of hydrochloric acid. This leads to the development of ulcers in the stomach and duodenum, which can lead to serious health consequences.

Zollinger-Ellison syndrome was first described in 1955 by two American doctors, Rudolf Zollinger and Ella Ellison. They noticed that patients with this disease often have ulcers in the stomach and intestines that cannot be treated with conventional methods.

The main causes of Zollinger-Ellison syndrome are tumors of the pancreas and stomach, which are capable of producing excess amounts of hydrochloric acid and enzymes. This can lead to the development of ulcers and bleeding, as well as other serious complications.

A number of techniques are used to diagnose Zollinger–Ellison syndrome, including endoscopy, computed tomography, and magnetic resonance imaging. Treatment of the syndrome depends on the cause of its development and may include surgical removal of the tumor, drug therapy and other methods.

It is important to note that Zollinger-Ellison syndrome is a rare disease, but it must be taken into account when diagnosing and treating gastric and intestinal ulcers. Timely identification and treatment of this syndrome can help prevent serious complications and improve the quality of life of patients.

Zollinger-Ellison syndrome

Zollinger–Ellison syndrome (ZES) is one of the most complex and insidious types of gastrinoma. Most of the research on surgical treatment of gastrointestinal bleeding is devoted to this disease. Most often this disease is diagnosed